TITLE

New Challenge to IP Innovation

AUTHOR(S)
MAEBIUS, STEVE; FREEL, EVA
PUB. DATE
October 2016
SOURCE
Pharmaceutical Executive;Oct2016, Vol. 36 Issue 10, p50
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents the results of a survey on the growing use by pharmaceutical industry of Inter Partes Reviews (IPRs), which offer third-party petitioners the opportunity to challenge the validity of a patent after it has been granted, while revealing some key considerations for originator companies in the U.S. The IPRs are considered as a cost-effective way to clear out Orange Book-listed patents of the U.S. Food and Drug Administration (FDA) before or during litigation.
ACCESSION #
120515876

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics